Efalizumab and lymphadenopathy Patient Reports February 11, 2012

Efalizumab Side Effects Report #4701383-5
Efalizumab side effect was reported by a Physician from on June 10, 2005. Male patient, 66 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: abnormal behaviour, cardioversion, dialysis , hallucination, lymphadenopathy, meningitis , pneumonia , renal failure, sepsis . Efalizumab dosage: 1 MG/KG , 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient died on 06/09/2005.

Efalizumab Side Effects Report #4745095-0
Efalizumab side effect was reported by a Physician from UNITED STATES on July 29, 2005. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: lymphadenopathy, sinusitis . Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX. Patient was hospitalized and became disabled. Patient recovered.

Efalizumab Side Effects Report #4796340-7
Efalizumab side effect was reported by a Physician from SWITZERLAND on Sept 22, 2005. Male patient, 48 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, cyst, infection , lymphadenopathy, psoriasis, pyrexia. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with MOXONIDINE, ALLOPURINOL, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4838331-3
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on Nov 08, 2005. Male patient, 48 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, condition aggravated, erythrodermic psoriasis, lymphadenopathy, psoriatic arthropathy, pyrexia, synovial cyst. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with MOXONIDINE, IRBESARTAN, ALLOPURINOL, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #4899529-1
Efalizumab side effect was reported by a Physician from GERMANY on Jan 17, 2006. Male patient, 48 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: condition aggravated, erythrodermic psoriasis, lymphadenopathy, psoriatic arthropathy, pyrexia, synovial cyst. Efalizumab dosage: 1MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with MOXONIDINE, IRBESARTAN, ALLOPURINOL, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4998727-6
Efalizumab side effect was reported by a Physician from GERMANY on May 05, 2006. Male patient, 48 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, condition aggravated, erythrodermic psoriasis, lymphadenopathy, psoriatic arthropathy, pyrexia, synovial cyst. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with MOXONIDINE, IRBESARTAN, ALLOPURINOL, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5152819-X
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2006. Male patient, 47 years of age, weighting 138.2 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, back pain , calcinosis, computerised tomogram abdomen abnormal, gout , lymphadenopathy, night sweats, polyarthritis, prostate examination abnormal. Efalizumab dosage: 70 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with COLACE, ULTRAVATE CREAM, DOVONEX CREAM, FLUOCINOLONE LOTION, CLOBEX, PROTONIX. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5179353-5
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2006. Male patient, 47 years of age, weighting 138.2 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: back pain , computerised tomogram abnormal, gouty arthritis, hyperhidrosis, lymphadenopathy, polyarthritis, prostate examination abnormal, psoriatic arthropathy, systemic inflammatory response syndrome. Efalizumab dosage: 70 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with COLACE, ULTRAVATE CREAM, DOVONEX CREAM, FLUOCINOLONE LOTION, CLOBEX, PROTONIX. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5669947-2
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on Mar 04, 2008. Female patient was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: herpes zoster, lymphadenopathy, pseudolymphoma. Efalizumab dosage: 0.8 ML, 1/WEEK. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #5808966-X
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on July 08, 2008. Female patient was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: fatigue, headache , herpes zoster, lymphadenopathy, nephrolithiasis, pleural effusion, pseudolymphoma. Efalizumab dosage: 0.8 ML, 1/WEEK. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5849704-4
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on Aug 12, 2008. Female patient was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: herpes zoster, lymphadenopathy, pseudolymphoma. Efalizumab dosage: 0.8 ML, 1/WEEK. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #6104218-1
Efalizumab side effect was reported by a Health Professional from ITALY on Feb 20, 2009. Male patient was diagnosed with psoriasis, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, hyperpyrexia, lymphadenopathy. Efalizumab dosage: 1 MG/KG, 1/WEEK. During the same period patient was treated with AMLODIPINE, NORVASC, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #6110419-9
Efalizumab side effect was reported by a Health Professional from ITALY on Mar 04, 2009. Male patient was diagnosed with psoriasis, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, hyperpyrexia, lymphadenopathy. Efalizumab dosage: 1 MG/KG, 1/WEEK. During the same period patient was treated with AMLODIPINE, NORVASC, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #6121662-7
Efalizumab side effect was reported by a Health Professional from ITALY on Mar 12, 2009. Male patient was diagnosed with psoriasis, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, hyperpyrexia, lymphadenopathy. Efalizumab dosage: 1 MG/KG, 1/WEEK. During the same period patient was treated with AMLODIPINE, NORVASC, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #6128060-0
Efalizumab side effect was reported by a Health Professional from ITALY on Mar 17, 2009. Male patient was diagnosed with psoriasis, hypertension and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, hyperpyrexia, lymphadenopathy. Efalizumab dosage: 1 MG/KG, 1/WEEK. During the same period patient was treated with AMLODIPINE, NORVASC, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient recovered.